advertisement
11.13.2 Betablocker and carbon anhydrase inhibitor (7)
Showing records 1 to 7
Display all abstracts in classification 11.13.2 Betablocker and carbon anhydrase inhibitor
Search within classification 11.13.2 Betablocker and carbon anhydrase inhibitor49015 Comparison of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations on Diurnal Intraocular Pressure Control in Primary Open-Angle Glaucoma
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 381-386
48901 Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma
Siesky B; Harris A; Ehrlich R; Cantor L; Shoja MM; Rusia D; Hollander DA; Abrams L; Williams JM; Shoshani Y
Advances in Therapy 2012; 29: 53-63
48855 Comparison of fixed combinations of dorzolamide/timolol and brimonidine/timolol in patients with primary open-angle glaucoma
Gulkilik G; Oba E; Odabasi M
International Ophthalmology 2011; 31: 447-451
48853 Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
Lorenz K; Rosbach K; Matt A; Pfeiffer N
Clinical Ophthalmology 2011; 5: 1745-1750
49150 Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
Shemesh G; Moisseiev E; Lazar M; Kurtz S
Clinical Ophthalmology 2012; 6: 283-287
49217 Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
Nakakura S; Tabuchi H; Baba Y; Maruiwa F; Ando N; Kanamoto T; Kiuchi Y
Clinical Ophthalmology 2012; 6: 369-375
48590 Twenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucoma
Konstas AG; Quaranta L; Yan DB; Mikropoulos DG; Riva I; Gill NK; Barton K; Haidich AB
Eye 2012; 26: 80-87
